↓ Skip to main content

Procaine treatments for cognition and dementia

Overview of attention for article published in Cochrane database of systematic reviews, October 2008
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)

Mentioned by

q&a
1 Q&A thread

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
128 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Procaine treatments for cognition and dementia
Published in
Cochrane database of systematic reviews, October 2008
DOI 10.1002/14651858.cd005993.pub2
Pubmed ID
Authors

Szabolcs Szatmári, Dániel Bereczki

Abstract

Procaine is a controversial substance which has been used for "antiageing" effects including cognitive improvement for more than 50 years.Preparations which contain procaine as a component are claimed to prevent, reverse and interrupt dementia. Several products are widely promoted and can be purchased "over the counter" outside the US and via the Internet. Procaine preparations are said to be readily available in over 70 countries and to be used by more than 100 million people.

Mendeley readers

The data shown below were compiled from readership statistics for 128 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Norway 2 2%
Japan 2 2%
Ireland 1 <1%
United Kingdom 1 <1%
Belgium 1 <1%
South Africa 1 <1%
Unknown 120 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 17%
Researcher 20 16%
Student > Bachelor 14 11%
Student > Postgraduate 11 9%
Student > Ph. D. Student 9 7%
Other 25 20%
Unknown 27 21%
Readers by discipline Count As %
Medicine and Dentistry 43 34%
Psychology 11 9%
Social Sciences 10 8%
Nursing and Health Professions 9 7%
Agricultural and Biological Sciences 6 5%
Other 16 13%
Unknown 33 26%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 February 2014.
All research outputs
#6,509,559
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#6,682
of 8,923 outputs
Outputs of similar age
#66,375
of 188,583 outputs
Outputs of similar age from Cochrane database of systematic reviews
#136
of 185 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 47th percentile – i.e., 47% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 188,583 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 185 others from the same source and published within six weeks on either side of this one. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.